Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. The Benefits and Challenges of Research in Humans January, 2011
2. I have heard about targeted therapies for breast cancer-but what is a life-cycle targeted therapy? January, 2011
3. Platform Presentation: COX-2 Dependent Collagen Fibrillogenesis Drives Metastasis in the Postpartum Mammary Gland January, 2011
4. Does postpartum breast involution account for the poor prognosis of pregnancy-associated breast cancer? January, 2011
5. Postpartum Mammary Gland Involution Drives Breast Cancer Progression through Collagen and COX-2 January, 2011
6. Posttparrttum Mammarry Glland IInvolluttiion Drriives Brreastt Cancerr Prrogrressiion tthrrough Collllagen and COX--2, January, 2011
7. Mammary Extracellular Matrix Proteins Contribute to Protective Effect of Parity: Insight into Tumor Cell Dormancy? January, 2011
8. Postpartum mammary gland involution drives DCIS progression through collagen and COX-2, identifying a target for intervention January, 2011
9. Postpartum mammary gland involution drives breast cancer progression through collagen and COX-2 identifying a target for intervention. January, 2011
10. Pregnancy Associated Breast Cancer: Role of Epithelium and Stroma in Tumor Aggressiveness January, 2011
11. Postpartum involution as a risk factor for Pregnancy-Associated Breast Cancer January, 2010
12. Phenotypic plasticity of mammary epithelial cells and implications for breast cancer development and treatment. January, 2010
13. Meet-the-Expert Session, Role of postpartum involution in the promotion of pregnancy-associated breast cancer January, 2010
14. Mammary Gland Involution as a Target for Breast Cancer Prevention: Insights from Macrophages and NSAIDS January, 2010
15. Mammary gland involution as a target for breast cancer prevention: insights from macrophages and NSAIDS January, 2010
16. What is the ECM microenvironment of life 1.0 and how is it different from life 1.1? January, 2010
17. The pro-inflammatory milieu of breast involution as a cancer prevention target January, 2009
18. Postnatal breast involution as a highly targeted window for breast cancer prevention January, 2009
19. Pro-inflammatory tissue remodeling of the postpartum breast and breast cancer progression January, 2009
20. Mammary Gland Involution Microenvironment and Tumor Progression January, 2009
21. The involution hypothesis and pregnancy associated breast cancer January, 2009
22. Information Conveyed by ECM Proteins in the Mammary Gland January, 2009
23. Pregnancy-associated Breast cancer: role of epithelium and stroma in tumor aggressiveness January, 2009
24. Physiologic Mammary Gland Involution Promotes Breast Cancer, Department of Genetics January, 2009
25. Role of mammary gland involution in promoting metastasis in pregnancy-associated breast cancer (PABC). January, 2008
26. Pregnancy-Associated Breast Cancer January, 2008
27. The inflammatory milieu permits metastasis in pregnancy-associated breast cancer January, 2007
28. Plasticity of the mammary gland extracellular matrix and breast cancer progression January, 2007
29. Wound healing signature of mammary gland involution and pregnancy associated breast cancer January, 2007
30. Identification of the Extracellular Matrix Proteomes Responsible for Breast Cancer Metastasis and Tumor Cell Dormancy January, 2007
31. The Inflammatory Milieu Permits Metastasis in Pregnancy-Associated Breast Cancer January, 2007
32. Functional Changes in Mammary ECM Induced by Endocrine State and Preventive Agents: Implications for Cancer Prevention. January, 2006
33. Microenvironment of the involuting mammary gland activates tumor metastasis January, 2006
34. Plasticity of the mammary gland extracellular matrix and breast cancer progression January, 2006
35. Microenvironment of the involuting mammary gland activates tumor metastasis: a new target for chemoprevention? January, 2006
36. Physiologic changes in mammary ECM determine tumor progression; implications for cancer prevention January, 2006
37. Microenvironment of the Involuting Mammary Gland Activates Tumor Angiogenesis and Metastasis January, 2005
38. Tamoxifen Treatment Functionally Alters the Rat Mammary Stroma Indicating a Role for the ECM in Tumor Suppression January, 2005
39. Remodeling of the mammary tumor microenvironment following pregnancy promotes tumor cell metastasis; a plausible mechanism for poor prognosis of pregnancy-associated Breast cancer January, 2005
40. Mammary gland tissue remodeling; target for breast cancer prevention, and Breast cancer prevention-focus on youth January, 2004
41. Tissue remodeling in the mammary gland as a target for breast cancer prevention January, 2004
42. Compositional changes in mammary ECM induced by endocrine state and preventive agents; implications for cancer progression January, 2004
43. Steps of metastasis from a tissue-interaction perspective January, 2003
44. Sexual Maturation, Mammary Gland Maturation and Risk for Breast Cancer are Differentially Affected by whole foods Compared to Preformed Vitamin A in the SD Rat. January, 2002
45. Mammary stroma is under endocrine regulation, implications for breast cancer prevention January, 2002
46. Adolescent Vitamin A Intake Alters Susceptibility to Mammary Carcinogenesis in the Sprague-Dawley Rat January, 2002
47. Role of the Extracellular Matrix in Breast Cancer Etiology and Prevention. January, 2002
48. Mammary extracellular matrix composition and function are under endocrine control; implications for chemoprevention January, 2001
49. Adolescent Vitamin A Intake Alters Susceptibility to Mammary Carcinogenesis in the Sprague-Dawley Rat. January, 2001
50. ECM isolated from post-lactational involuting mammary glands promotes death in normal mammary epithelial cells and invasion in tumor cells; implications for mammary carcinogenesis. January, 2001
51. Role of pre-formed vitamin A intake during adolescence and mammary carcinogenesis adult Sprague Dawley rat January, 2000
52. Reproductive state of rat mammary gland ECM modulates human breast cancer cell migration and invasion January, 1999
53. Pathology of Breast Cancer, Relevance of Animal Models January, 1998
54. Targeting Mammary Epithelial-ECM Interactions with Chemopreventive Agents January, 1997
55. Targeting Mammary Epithelial-ECM interactions with Chemopreventive Agents January, 1995
56. Tissue-Autonomy, Timing and Reversibility of Sex Determination January, 1988
57. Intestinal Mosaicism for Expression of Vitellogenin Genes January, 1985



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Mammary gland involution drives breast cancer progression through collagen and COX-2 28th IABCR/Breakthrough Breast Cancer Conference April, 2012

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.